Been tied-up with buying some gold stks at the top of today's mkt!
So using this morning's SP lets redo the calcs re what we hope to see in Monday's HY report for BRS:
FY15 EBITDA was 265m giving underlying NPAT of 72m = EPS of 14.0c.
Fy16 EBITDA of 290m gives underlying NPAT of aprox 78.8m and guesstimated EPS of 15.3c.
FY17 expected EBITDA of 300+m gives underlying NPAT of aprox 81.5m and est. EPS of 15.8c.
Tax increases, but interest decreases as the debt is rapidly reduced.
SP of 105c/15.8 = PE 6.65x for FY17.
Not bad for a company that has revenue locked-in for the next 18 months and plenty time to win additional contracts. But is the 300m EBITDA estimate from BRS dependent on BRS winning the refugee contract for 5 yrs starting on 01/03/17? I suspect it does and hope this is explained in the release. But what i'm most keen to read is how well BRS is doing from the numerous other contracts the firm holds. Are these now profitable after yrs of losing money?
SP hammered down again this morn in a weak mkt. Anyone buying/topping-up?
BRS Price at posting:
$1.05 Sentiment: Buy Disclosure: Held
